World / Health & Beauty
Majority Of Subjects Report That Music Sounds Pleasant With Their MAESTRO Cochlear Implant
10.07.2008 08:16
medicalnewstoday.com
MED-EL Corporation has announced new data regarding FineHearingTM technology, available only with the MAESTRO™ Cochlear Implant System. In addition to hearing in "high definition" with FineHearing, MED-EL's MAESTRO system offers the smallest internal implant and the thinnest, lightest externally-worn speech processor available.
World
Hearing Disorders
U.S. Health Authorities Report Reduction In Rotavirus Disease After The Introduction Of Pentavalent Rotavirus Vaccine RotaTeq(R)
10.07.2008 08:15
medicalnewstoday.com
Findings from the U.S. Centers for Disease Control and Prevention (CDC) show that rotavirus disease was dramatically reduced in the United States from November 2007 through May 2008 compared to previous years. The findings were published in the CDC's Morbidity and Mortality Weekly Report on the 26th June.1 RotaTeq®, Merck & Co. Inc.'s and Sanofi Pasteur MSD's pentavalent oral rotavirus vaccine was introduced in February 2006 in the U.S.
World
Gastroenterology
Better Outcomes In Heart Attack Patients Linked To Chest Pain Center Accreditation
10.07.2008 08:15
medicalnewstoday.com
Hospitals accredited by the Society of Chest Pain Centers (SCPC) have been shown to perform better in the heart attack core measures established by Centers for Medicare and Medicaid Services (CMS) as compared to non-accredited hospitals, according to a national study led by an Emory University researcher.
World
Cardiology
Introgen To Host Conference Call With Clinical Investigators To Discuss Phase III Data And ADVEXIN Registration Activities
10.07.2008 08:15
medicalnewstoday.com
Introgen Therapeutics, Inc. (NASDAQ:INGN) announced that it will host a conference call with management and invited clinical experts on Thursday, July 10, 2008 at 3:30 p.m. ET. Introgen management will discuss its recent ADVEXIN regulatory approval filings and phase III clinical data. In addition, several clinical investigators will be available to respond to questions. These clinicians to include, Dr.
World
Cancer
In Spite Of Setbacks, Therapeutic Cancer Vaccines Continue To Make Gains - Immune Science Associates Assessment Analyzes Evolving Strategies
10.07.2008 08:15
medicalnewstoday.com
Efforts to up-regulate the human immune system to recognize and destroy tumor cells with minimal side effects and collateral damage to healthy tissue continue to attract a mixture of optimism and determination from vaccine developers and skepticism from potential Pharma partners.
World
Cancer
Mind Over Matter In Chronic Disease Treatment, Queensland University Of Technology
10.07.2008 07:18
medicalnewstoday.com
A study by QUT sleep psychologists is shedding light on why some people with life-threatening conditions do not adhere to medical treatment, even when "it's for their own good".
World
Psychiatry
Internists Applaud Senate Vote To Pass H.R. 6331 And Avert Physician Payment Cut, Noting Bipartisan 'Veto Proof' Majority, USA
10.07.2008 07:18
medicalnewstoday.com
"The Senate gave overwhelming, bipartisan approval to legislation to avert Medicare physician payment updates--the best outcome possible given the difficult circumstances facing us," Jeffrey P. Harris, MD, FACP, president of the American College of Physicians (ACP) said today. "We implore President Bush to immediately sign this bill into law. The votes in both the Senate and House in favor of H.R.
World
Critical Care Medicine & Anesthesiology
June 2008 NPA Board Meeting
10.07.2008 07:18
medicalnewstoday.com
NPA Chairman, Paul Bennett, comments on some of the items discussed at the June 2008 board meeting 1. Pharmacists and their staff should be designated "front line worker" status in the case of emergencies "Preparation for the actions required during a national emergency, for example a 'flu pandemic, are well advanced in the UK. However, at present, pharmacists have not been assured that their role as "front line workers" is recognised.
World
Pharmaceutics
Online Courses Boost Infection Control Skills That Could Prove Vital In A Pandemic
10.07.2008 07:18
medicalnewstoday.com
Online courses are helping staff to develop the skills they need to tackle hospitalacquired infections, such as MRSA and C.difficile, and this expertise could also prove vital in a pandemic, according to a study published in the latest issue of the UK-based Journal of Advanced Nursing.
World
Food and Drug Administration
Barnardo's Response To The Review Of Child And Adolescent Mental Health Services, UK
10.07.2008 07:17
medicalnewstoday.com
Barnardo's submitted its response to the Department for Children, Schools and Families this week as part of the independently commissioned review of CAMHS. Barnardo's continues to be encouraged by CAMHS recent initiatives, which have helped to focus Government thinking on promoting emotional wellbeing and positive mental health.
World
Mental Disorders
Naturopaths Support Tougher Regulation Of Complementary Medicine
10.07.2008 07:17
medicalnewstoday.com
Naturopaths are strongly in favour of regulation of their industry, a University of Queensland researcher has found. Naturopaths believed that regulation would lift the quality of practitioners, improve patient safety, promote research and allow for greater collaboration between complementary and conventional medicine, researcher Jon Wardle, a PhD student with the School of Population Health, said.
World
Alternative Medicine
Institute Professor Wins Prestigious Science Award, UK
10.07.2008 07:17
medicalnewstoday.com
The Institute of Cancer Research's Professor Christopher Marshall FRS has been awarded the Royal Society's prestigious 2008 Buchanan Medal. The medal is in recognition of his outstanding contribution to understanding how cancers develop and identifying major targets for cancer therapeutic treatments. The Royal Society, the UK's national academy of science, awards the Buchanan Medal every two years in recognition of distinguished contribution to the medical sciences.
World
Cancer
Merck Serono: Erbitux(R) Phase III Clinical Study In Gastric Cancer Started
10.07.2008 07:17
medicalnewstoday.com
Merck Serono, a division of Merck KGaA, announced that the first patient has been enrolled into its pivotal Phase III gastric cancer clinical study, EXPAND (Erbitux in combination with Xeloda and cisplatin in advanced esophago-gastric cancer).
World
Cancer
National Autistic Society Response To The Bercow Review On Children, Young People And Speech, Language And Communication, UK
10.07.2008 07:16
medicalnewstoday.com
The Bercow review has confirmed what many parents of children with autism have been telling us: provision for children with speech, language and communication needs is inadequate and must improve. We strongly welcome Bercow's crucial emphasis on early identification and intervention and support his call for an assessment process and better speech and language services.
World
Autism
CYT003-QbG10 Monotherapy For The Treatment Of Allergic Diseases Is Safe And Efficacious In Placebo-Controlled Phase II Study
10.07.2008 07:16
medicalnewstoday.com
Cytos Biotechnology Ltd (SWX:CYTN) announced results from two randomized, double-blind, placebo-controlled, multicentre phase II studies with CYT003-QbG10 monotherapy for the treatment of house dust mite and cat allergy, and with CYT005-AllQbG10 combination therapy for the treatment of house dust mite allergy.
World
Allergy
English